To determine the in vivo role played by BAFF in the development of liver fibrosis, we studied the NASH model using BAFF-deficient mice and found that BAFF-deficient mice were protected from developing not only steatosis but also NASH and fibrosis. This evidence concerns the gene TNFSF13B and Hepatic fibrosis.